IL17A and psoriasis: Reduces psoriasis symptoms including thickness, erythema, and scales of skin lesions; increases Th2 cells; and reduces enrichment of inflammatory cytokines (IL-17A, IFN-γ, IL-6, TNF-α) in spleen and skin lesions